Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News SQI Diagnostics Inc. V.SQD

Alternate Symbol(s):  SQIDF

SQI Diagnostics are leaders in the science of lung health. We develop and manufacture respiratory health and precision medicine tests that run on SQI's automated systems. Our tests simplify and improve COVID19 antibody monitoring, Rapid Acute Lung Injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada and Europe. More than half of its revenues come from the United States.


Recent & Breaking News (TSXV:SQD)

SQI Diagnostics Reports Second Quarter 2021 Results and Announces Departure of CEO and Appointment of Interim CEO

Canada NewsWire May 21, 2021

SQI Diagnostics and McMaster University Announce $900,000 Collaborative Research and Development Grant

Canada NewsWire April 13, 2021

SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization

PR Newswire April 1, 2021

SQI Diagnostics Receives $2.3 Million in Funds from Shareholder Exercise of Securities

Canada NewsWire March 8, 2021

SQI Diagnostics Reports First Quarter 2021 Results

Canada NewsWire March 1, 2021

SQI Diagnostics Announces New Corporate Website

Canada NewsWire February 18, 2021

SQI Diagnostics Announces Proposed Insider Sales and Warrant Exercises to Fund Company

Canada NewsWire February 10, 2021

SQI Diagnostics Reports Fourth Quarter and Fiscal 2020 Results

Canada NewsWire January 27, 2021

SQI Diagnostics Announces Patient Enrollment Begins for Its COVID-19 HOME Antibody Test Clinical Study

Canada NewsWire January 25, 2021

Acquisition of Common Shares of SQI Diagnostics Inc.

Canada NewsWire December 31, 2020

SQI Diagnostics Announces $4 Million Funding via Warrant Exercise by Insiders

Canada NewsWire December 30, 2020

SQI Diagnostics Updates Clinical Progress on Novel COVID-19 Tests Under Development for U.S. FDA Regulatory Submission

Canada NewsWire October 26, 2020

SQI Diagnostics and McMaster University Researchers Create New Technology to Better Measure Severity of COVID-19 Disease

Canada NewsWire October 20, 2020

SQI Diagnostics Expanding Business into Rapid Diagnostic Testing Market

GlobeNewswire September 9, 2020

SQI Diagnostics Reports Third Quarter 2020 Results

Canada NewsWire August 27, 2020

SQI Diagnostics Inc. Announces Stock Option Grant

Canada NewsWire August 27, 2020

IIROC Trading Resumption - SQD

Canada NewsWire August 18, 2020

SQI Diagnostics Appoints Rob Chioini as Chief Executive Officer, Grants Options and Amends Stock Option Plan

Canada NewsWire August 18, 2020

IIROC Trading Halt - SQD

Canada NewsWire August 18, 2020

SQI Diagnostics Inc. Announces Warrant Exercise by Insiders

Canada NewsWire July 3, 2020